Jeffrey William Henderson
CIK 1324015 · Chief Financial Officer · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.47M
Companies
7
Total Filings
100
Lifetime Open-Market Net
-$73.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTI | Director | 36,572 | — | — | -$3.32M | 19 | 2026-05-07 |
| QCOM | Director | 14,598 | $211.72 | $3.09M | -$1.47M | 22 | 2026-03-18 |
| BDX | Director | 9,158 | $146.24 | $1.34M | $350.4K | 4 | 2026-01-29 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 28,866 | $9.75 | $281.4K | -$133.4K | 12 | 2023-09-06 |
| BECTON DICKINSON & CO (BDXB) Delisted | Director | 4,653 | $48.16 | $224.1K | $0 | 3 | 2023-01-26 |
| BECTON DICKINSON & CO (BDXA) Delisted | Director | 2,089 | — | — | $0 | 2 | 2020-01-30 |
| CAH | Chief Financial Officer | 67,190 | $223.85 | $15.04M | -$68.60M | 38 | 2014-08-28 |
Recent Filings · Page 2 of 10
100 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-10 | BDX | Buy (P) | +1,500 | $350.4K | EDGAR |
| 2025-02-04 | HTI | Sell (S) | −5,000 | -$281.5K | EDGAR |
| 2025-01-30 | BDX | Grant (A) | +930 | $0 | EDGAR |
| 2025-01-07 | HTI | Sell (S) | −10,000 | -$500.1K | EDGAR |
| 2024-04-29 | HTI | Grant (A) | +6,501 | $0 | EDGAR |
| 2024-03-11 | QCOM | Exer (M) | +2,056 | $0 | EDGAR |
| 2024-03-07 | QCOM | Grant (A) | — | $0 | EDGAR |
| 2024-01-25 | BDX | Grant (A) | +900 | $0 | EDGAR |
| 2023-09-06 | KYNTRA BIO, INC. (FGEN) Delisted | Sell (S) | −2,000 | -$2.1K | EDGAR |
| 2023-08-08 | KYNTRA BIO, INC. (FGEN) Delisted | Sell (S) | −2,000 | -$3.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.